Lord Abbett Health Care Fund Class A (LHCAX)

Fund Assets	8.74M
Expense Ratio	1.074%
Min. Investment	$1,500
Turnover	91.00%
Dividend (ttm)	0.03
Dividend Yield	0.14%
Dividend Growth	-44.54%
Payout Frequency	Annual
Ex-Dividend Date	Dec 2, 2025

Previous Close	23.73
YTD Return	5.42%
1-Year Return	15.19%
5-Year Return	22.81%
52-Week Low	20.45
52-Week High	25.01
Beta (5Y)	0.71
Holdings	55
Inception Date	Jul 31, 2019

About LHCAX

Lord Abbett Health Care Fund Class A is an actively managed mutual fund focused on achieving long-term capital appreciation by investing primarily in companies within the health care sector. The fund allocates at least 80% of its net assets to equity and equity-related securities of health care-related firms, making it a targeted vehicle for gaining exposure to the diverse and evolving health care industry. Its portfolio typically includes leading pharmaceutical, biotechnology, and medical device companies, with notable holdings in firms such as Eli Lilly, Novo Nordisk, and Intuitive Surgical. This fund is designed to participate in the growth dynamics of the global health care sector, addressing areas such as drug development, diagnostic tools, and advanced medical technologies. It is categorized as a mid-growth fund and holds a diversified mix of about 58 companies, with approximately 39.5% of assets in its top ten positions. While the fund offers access to a sector with significant long-term growth potential driven by innovation and demographics, it features a front-end sales charge and a relatively high expense ratio compared to its peers. Lord Abbett Health Care Fund Class A plays a specialized role for investors seeking sector-specific exposure within the broader equity markets.

• Fund Family: Lord Abbett
• Category: Health
• Performance Rating: Average
• Risk Rating: Average
• Stock Exchange: Nasdaq
• Ticker Symbol: LHCAX
• Share Class: Class A
• Index: MSCI ACWI/Health Care NR Index

Performance

LHCAX had a total return of 15.19% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.55%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
LHCOX	Class F3	0.68%
LHCVX	Class R6	0.68%
LHCIX	Class I	0.78%
LHCFX	Class F	0.78%

Top 10 Holdings

44.28% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	10.72%
UnitedHealth Group Incorporated	UNH	5.57%
Johnson & Johnson	JNJ	5.11%
Novartis AG	NOVN	4.32%
Natera, Inc.	NTRA	3.71%
Gilead Sciences, Inc.	GILD	3.64%
CVS Health Corporation	CVS	3.44%
Guardant Health, Inc.	GH	2.69%
Galderma Group AG	GALD	2.68%
Thermo Fisher Scientific Inc.	TMO	2.39%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 2, 2025	$0.0335	Dec 2, 2025
Nov 26, 2024	$0.0604	Nov 26, 2024
Nov 23, 2021	$1.4724	Nov 23, 2021
Nov 24, 2020	$2.3119	Nov 24, 2020

Data Sources: Tiingo, Alpha Vantage, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Alpha Vantage. Several fund data points are also provided by Finnhub.

Last checked:

Oct 17, 2026

Data Sources Report a data error